Power-Pak is pleased to present a complimentary CE Webinar. |
|
Goal To provide managed care clinicians with awareness and knowledge of fibrodysplasia ossificans progressiva (FOP) – etiology; epidemiology; and medical, supportive, and rehabilitation management; as well as emerging pharmacological therapies, thus improving outcomes. |
|
Learning Objectives At the conclusion of this program, the learner will be able to do the following: |
• |
Describe therapeutic options and their mechanisms of action for advanced ovarian and endometrial cancers |
• |
Appraise the safety and efficacy of current treatment considerations for advanced ovarian and endometrial cancers |
• |
Formulate effective strategies to manage patients’ adherence and unique adverse events when utilizing PARP inhibitors, immune checkpoint inhibitors, and TKIs for the management of advanced ovarian and endometrial cancers |
Accreditation Statements | ||
|
||
|
||
Agenda |
||
Introduction (5 minutes) Presentation (45 minutes) Conclusions & Question & Answer Session (10 minutes) |
How to Earn Credit Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor. |
||||||||||||
Required Computer Hardware/Software Please ensure the computer system you plan to use meets the following minimum requirements: |
||||||||||||
|
||||||||||||
|